Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

GSK Investigational Site, Taipei

GSK Investigational Site, Taipei

GSK Investigational Site, Taipei

GSK Investigational Site, Taoyuan

GSK Investigational Site, Taichung

GSK Investigational Site, Changhua

GSK Investigational Site, Rochester

GSK Investigational Site, Turku

GSK Investigational Site, Hamburg

GSK Investigational Site, Norfolk

GSK Investigational Site, Pori

GSK Investigational Site, Spartanburg

GSK Investigational Site, Mt. Pleasant

GSK Investigational Site, The Villages

GSK Investigational Site, Tampere

GSK Investigational Site, Coral Gables

GSK Investigational Site, Fort Myers

GSK Investigational Site, Sarasota

GSK Investigational Site, Mobile

GSK Investigational Site, Taichung

GSK Investigational Site, Essen

GSK Investigational Site, Essen

GSK Investigational Site, Goch

GSK Investigational Site, Evansville

GSK Investigational Site, Mainz

GSK Investigational Site, Richfield

GSK Investigational Site, Seinäjoki

GSK Investigational Site, Kansas City

GSK Investigational Site, Kokkola

GSK Investigational Site, Wichita

GSK Investigational Site, San Antonio

GSK Investigational Site, Munich

GSK Investigational Site, Phoenix

GSK Investigational Site, Oulu

GSK Investigational Site, San Diego

GSK Investigational Site, Riverside

GSK Investigational Site, Wallerfing

GSK Investigational Site, Würzburg

GSK Investigational Site, Wenatchee

GSK Investigational Site, Espoo

GSK Investigational Site, Helsinki

GSK Investigational Site, Helsinki

GSK Investigational Site, Järvenpää

GSK Investigational Site, Fukuoka

GSK Investigational Site, Kumamoto

GSK Investigational Site, Tokyo